Diagnostic News and Research

RSS

Body dysmorphic disorder - “Manorexia”, among weight lifters: Study

More than 10 per cent of weightlifters, in a study conducted by Southern Cross University in northern NSW, believe that they are too small, and may suffer from a psychological disorder known as muscle dysmorphia. Tthe psychological condition has been nicknamed as “reverse anorexia” or “manorexia.” and is usually characterized by sufferers being determined to become more muscular, despite some exhibiting more muscles than the average person.

8 Mar 2012

Metformin drug appears to prevent growth of atherosclerosis in patients with HIV

Treatment with the common diabetes drug metformin appears to prevent progression of coronary atherosclerosis in patients infected with HIV.

8 Mar 2012

Women with breast pain do not gain benefit from imaging

Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have found that women with breast pain who receive imaging (mammograms, MRIs or ultrasounds) as part of breast pain evaluation, undergo follow-up diagnostic testing, but do not gain benefit from these additional studies.

8 Mar 2012

March issue of NeuroPerspective reviews therapeutics for ADHD

NeuroPerspective, the independent, monthly review of the neurotherapeutics area, has released its March issue, which reviews the field of therapeutics for Attention Deficit Disorder.

8 Mar 2012

First 'theranostic' agent for treatment of ALL

A team of researchers at Case Western Reserve University School of Medicine has developed the first "theranostic" agent for the treatment of acute lymphoblastic leukemia (ALL).

8 Mar 2012

Transgenomic fourth quarter total revenue increases 68% to $8.6M

Transgenomic, Inc. today reported financial results for the year ended December 31, 2011 and provided a business update.

7 Mar 2012

Colon cancer screening guidelines released

According to a new guidance statement from the American College of Physicians all adults should get screened for colon cancer once they get older to reduce their risk of dying from the nation's number two cancer killer.

7 Mar 2012

e-Health records don't always equal reduced costs

A study published in Health Affairs found that electronic health records don't necessary lead to reducing health care spending or fewer diagnostic tests.

7 Mar 2012

Pharmspective releases first knowledge management application: ClearView

Pharmspective, LLC today announced the release of its first knowledge management application - ClearView - specifically developed to analyze provisions in the health care reform law and their impact on key pharma customer decision makers who influence product adoption.

7 Mar 2012

Whole-body CT more effective at determining life-threatening injuries

For assessing severe trauma, single-pass whole-body computed tomography (CT) can prove but not definitively exclude the presence of injuries and should be performed later than 30 minutes after admission to an emergency department for optimal results, according to a study in CMAJ.

6 Mar 2012

Neuroimaging for stroke patients may be unnecessarily costly and redundant

Neuroimaging for stroke patients may be unnecessarily costly and redundant, contributing to rising costs nationwide for stroke care, according to University of Michigan research.

6 Mar 2012

Community Health Systems subsidiary merges with Diagnostic Clinic of Longview

Community Health Systems, Inc. announced today that a subsidiary of the Company has merged operations with Diagnostic Clinic of Longview, P.A., a large multi-specialty clinic serving residents of Longview, Texas, and surrounding East Texas communities.

6 Mar 2012

New DNA-reading technology could lead to correct genetic diagnosis for muscle-wasting diseases

Scientists at The University of Nottingham have used a revolutionary new DNA-reading technology for a research project that could lead to correct genetic diagnosis for muscle-wasting diseases.

6 Mar 2012

FDA clears UELS contactless breast cancer imaging tool

UE LifeSciences Inc. (UELS), a medical device manufacturer focused on providing novel breast cancer screening solutions, announced today that it has received market clearance from the U.S. Food and Drug Administration (FDA) for its NoTouch BreastScan™ device. NoTouch BreastScan™ is a contactless breast-imaging tool cleared by the FDA specifically for adjunctive diagnostic screening for the detection of breast cancer.

5 Mar 2012

Abbott, GenLab collaborate to develop new assay for PLEX-ID automated microbial identification system

Abbott announced today it will collaborate with Genetics Laboratory, Inc. on the development of a molecular diagnostic test that will be designed to rapidly detect microorganisms that cause orthopedic infections.

5 Mar 2012

Repligen seeks EMA marketing approval for SecreFlo for pancreatic imaging

Repligen Corporation announced today that it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for SecreFlo to improve detection of pancreatic duct abnormalities in patients with pancreatitis.

5 Mar 2012

Varian to acquire InfiMed

Varian Medical Systems, Inc., today announced it has reached an agreement to acquire InfiMed, Inc., a privately-owned, leading supplier of workstations including hardware and software for processing diagnostic X-ray images. The acquisition, which is expected to close in early April subject to the satisfaction of certain closing conditions, will operate within Varian's X-Ray Products segment.

5 Mar 2012

diaDexus introduces new PLAC Activity test in Europe

diaDexus, Inc., a company focused on the development and commercialization of proprietary cardiovascular diagnostic products, today announced the commercial launch of its CE-marked PLAC Test for Lp-PLA(2) Activity in Europe.

5 Mar 2012

Emotional inhibition and alexithymia are distinct phenomena: Study

In the early 80s Robert Kellner developed the Emotional Inhibition Scale (EIS), a self-rating scale for emotional inhibition based on clinimetric principles. This study explores whether the EIS differentiated a sample of cardiac recipients from normal controls, as well as the associations between the EIS and 2 measures of alexithymia, i.e. the Toronto Alexithymia Scale-20 (TAS-20) and the Diagnostic Criteria for Psychosomatic Research.

3 Mar 2012

Call for Expression of Interest to attend personalised medicine conference

The Call for Expression of Interest to attend or present at the Conference on Personalised Medicine: Better Healthcare in Cyprus in June 2012 is now open. The deadline is 1 April 2012.

2 Mar 2012